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ABSTRACT
CRISPR-Cas (clustered regularly interspaced short
palindromic repeats and the associated genes) con-
stitute adaptive immune systems in bacteria and ar-
chaea and they provide sequence specific immu-
nity against foreign nucleic acids. CRISPR-Cas sys-
tems are activated by viral infection. However, little is
known about how CRISPR-Cas systems are activated
in response to viral infection or how their expres-
sion is controlled in the absence of viral infection.
Here, we demonstrate that both the transcriptional
regulator Csa3b, and the type I-A interference com-
plex Cascade, are required to transcriptionally re-
press the interference gene cassette in the archaeon
Sulfolobus. Csa3b binds to two palindromic repeat
sites in the promoter region of the cassette and facil-
itates binding of the Cascade to the promoter region.
Upon viral infection, loading of Cascade complexes
onto crRNA-matching protospacers leads to relief of
the transcriptional repression. Our data demonstrate
a mechanism coupling CRISPR-Cas surveillance of
protospacers to transcriptional regulation of the in-
terference gene cassette thereby allowing a fast re-
sponse to viral infection.
INTRODUCTION
Clustered regularly interspaced short palindromic repeats
(CRISPR) and their CRISPR associated genes (cas) con-
stitute the CRISPR-Cas immune system. This system pro-
vides immunity against invading genetic elements in most
archaeal and many bacterial species (1,2). Short DNA frag-
ments originating from an invading virus or plasmid are
incorporated into the repeat-spacer array adjacent to the
CRISPR leader, in a process known as adaptation (3–5).
The CRISPR leader harboring a promoter initiates tran-
scription of the CRISPR locus and the long pre-crRNA
transcript is then processed to generate mature CRISPR
RNAs (crRNAs) that are bound by Cas proteins to form ri-
bonucleoprotein complexes for interference (6–9). Interfer-
ence complexes have been classified into three major types
(I, II and III) and two putative minor types (IV and V)
(10). Among these, CRISPR-Cas type I is most widespread
in nature and the interference complex is termed Cascade
(CRISPR-associated complex for antiviral defense) (10,11).
Since the first experimental demonstration of the anti-
viral function of the CRISPR-Cas systems (1), major efforts
in the field have been dedicated to elucidating the structural
and functional characteristics of CRISPR-Cas adaptation,
transcription/processing and interference (12). In contrast,
much less is known about how CRISPR-Cas systems are
regulated. Among the few studies reported, Agari et al. in-
vestigated the genome wide transcription profile of Ther-
mus thermophilus HB8 upon infection by the lytic phage
YS40. Expression of the majority of cas genes were found
to be significantly upregulated at 75 min post phage infec-
tion (13). Similarly, Quax et al. also detected upregulation
of the majority of CRISPR arrays and interference gene
cassettes in Sulfolobus islandicus LAL14/1 upon infection
by rudivirus SIRV2. The expression of two type I-A gene
cassettes, one type I-D gene cassette and one type III-B gene
cassette reached the highest level at 1 h post infection, while
expression of another type I-D gene cassette continued in-
creasing (14).
The differential expression of CRISPR-Cas systems
upon viral infection strongly indicates the involvement of
transcription regulators. However, very few transcription
regulators involved in CRISPR-Cas transcriptional control
have been studied. In Escherichia coli K12, the heat-stable
nucleoid structuring protein (H-NS), which recognizes and
silences the expression of foreign DNA with high AT con-
tent relative to the resident genome, was also shown to be
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involved in silencing CRISPR-cas promoters (15). More-
over, H-NS-mediated repression of CRISPR-based immu-
nity could be relieved by a LysR-type transcription fac-
tor LeuO through direct binding to two sites flanking the
casA promoter and the H-NS nucleation site (16). BaeR ac-
tivated by envelope stress can also promote release of H-
NS mediated cas repression by serving as an antagonist for
H-NS binding (17). CRP represses type I-E CRISPR-Cas
system in E. coli by competing with the activator LeuO
(16,18), whereas in Pectobacterium atrosepticum it activates
type I-F CRISPR-Cas transcription. In P. atrosepticum,
GalM regulates the cas transcription through CyaA and
CRP (19). Apart from transcriptional regulation, the high-
temperature protein G (HtpG) chaperone can affect the
CRISPR-Cas system in E. coli by stabilizing its client pro-
tein Cas3 (20). Even fewer studies have been on archaea
where the transcriptional regulator Csa3a (SiRe0764), as-
sociated with the CRISPR-Cas adaptation gene cassette
(SiRe0763-0760) in the genome of Sulfolobus islandicus
Rey15A, was shown to activate the transcription of adapta-
tion genes and trigger de novo CRISPR spacer acquisition
(21).
Here, we report on the transcriptional co-regulation of
CRISPR-Cas type I-A interference gene cassettes by both
Csa3b (SSO1444 and SiRe0765, sharing 87% identity) and
the Cascade complex in the archaeon Sulfolobus. The puta-
tive transcriptional regulator Csa3b is about 23 kDa carry-
ing a CARF (CRISPR associated Rossmann fold) domain
and a HTH (helix-turn-helix) domain (22). It differs signif-
icantly from Csa3a and its corresponding gene associates
tightly with type I-A interference gene cassettes consisting
of csa5, cas7, cas5, cas3′, cas3′′, cas8a and cas6 (10) (Fig-
ure 1A). Recently we reported that expression of the type
I-A interference gene cassette is regulated (23). We have
shown that Csa5 generates conditional toxicity in S. solfa-
taricus. Under the control of its native promoter Pcas (77
bp upstream of the Csa5 start codon) in a shuttle vector
pEXA2, Csa5 is toxic in CRISPR-Cas-deficient mutant S.
solfataricus Sens1 but not in S. solfataricus InF1 contain-
ing functional CRISPR-Cas systems (23). InF1 encodes six
CRISPR arrays (A-F), three type I-A gene cassettes and
four type III gene cassettes (24). Sens1 contains only arrays
E-F, one type III gene cassette and one incomplete type I-A
gene cassette (25,26). As the Csa5 toxicity in Sens1 cells was
found to be related to its high expression level and protein
oligomerization, we inferred that the absence of Csa5 toxi-
city in InF1 cells is due to, at least partially, the repression
of csa5 transcription by CRISPR-Cas related genes.
Here, we demonstrate that both Csa3b and the Cascade
complex bind to the promoter region of CRISPR-Cas type
I-A interference gene cassettes and function as transcrip-
tional repressors. Upon viral infection, redistribution of
the Cascade complex to the crRNA-matching protospac-
ers leads to relief of transcriptional repression thereby al-
lowing a fast transcriptional response, and potentially high
interference levels to viral infection.
MATERIALS AND METHODS
Strains, media and growth conditions
Sulfolobus strains used in this study are listed in Supple-
mentary Table S1 with the genotype indicated. S. islandicus
LAL549 was isolated by spreading S. islandicus LAL14/1
on plates containing uracil and FOA as described previ-
ously (27). It carries a deletion of 549 bp (1 301 868–1 302
416 bp) inside pyrF gene. Sulfolobus strains were grown at
78◦C in basic salt medium (28) supplemented with 0.2%
Glucose, 0.2% Casamino Acids, 0.005%Yeast extract and a
vitamin mixture (GCVY). When needed, arabinose (0.2%)
was substituted for glucose to induce gene expression from
the arabinose promoter on different plasmid constructs
(ACVY). E. coli strain DH5 and Rosetta cells were used
for DNA cloning and recombinant protein production. All
E. coli strains were cultured at 37◦C in Lysogeny Broth sup-
plemented with final concentration of 100 g/ml ampicillin
or 30 g/ml kanamycin as required.
Plasmid construction
Detailed information about cloning vectors, restriction sites
and PCR primers for the construction of the plasmids are
indicated in Supplementary Table S2. In case of cloning
two or more different fragments into the same vector, fu-
sion PCR was performed before cloning and all the four
or six primers are indicated. The genome-editing plasmids
were constructed following the protocol described previ-
ously (29,30). A DNA fragment carrying two copies of type
I-A CRISPR repeat separated by two oppositely oriented
SapI recognition sequences was inserted into pEXA2 be-
tween NdeI and MluI sites adjacent to the arabinose pro-
moter. To facilitate the insertion of mutant allele, an XhoI
restriction enzyme site was added adjacent to SphI to con-
struct the basic genome-editing plasmid pGE1 (Supple-
mentary Figure S1). pGE2 was constructed by replacing
type I-A CRISPR repeat with type I-D CRISPR repeat
in pGE1. To construct each specific genome-editing plas-
mid, the spacer DNA fragment was prepared by annealing
two complementary oligonucleotides and the resultant ds-
DNA carrying 3 nt overhangs was inserted into the SapI
sites of pGE1 or pGE2. Next, donor DNA fragments con-
taining a mutant allele of target gene were obtained by fu-
sion PCR and the PCR product was inserted between the
SphI and XhoI sites of the mini-CRISPR array containing
pGE1 or pGE2, giving complete genome editing plasmids
named pGE1 (or pGE2)-target site-Strain (Supplementary
Table S2).
Construction of gene or CRISPR array knockout mutants
csa3b and cas8a were deleted from E233S based on
the marker insertion and unmarked target gene dele-
tion method (MID) (31) using plasmids pMID-csa3b and
pUC19-cas8a (Supplementary Table S2), respectively. The
CRISPR array deletion mutants were obtained using the
CRISPR-based genome editing method (30). To knock-
out the two arrays in E233S, pGE1-Array12-E233S (Sup-
plementary Table S2) was transformed into E233S and
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Figure 1. The 77 bp Pcas contains sequence elements required for transcriptional repression. (A) Schematic presentation of the CRISPR-Cas type I-A
interference gene cassette of S. solfataricus studied in this work, along with the associated CRISPR array (containing 31 spacers) and the following type
I-A adaptation gene cassette. Both gene ID (SSO numbers) and cas nomenclature are shown for each gene. The Pcas orientation and start site are indicated
(bended arrow). (B) Depiction of csa5-containing inserts cloned into three constructs (pcsa5-39, −62 and −77) based on plasmid vector pEXA2. As
reference, the position and orientation of chromosomal Pcas (black bar) in relation to csa3 (gray arrow) and csa5 (black arrow) is indicated on top of the
three inserts. (C) Transformation efficiency of different csa5-containing constructs in Sens1 (lacking functional CRISPR-Cas) and InF1 cells.
the plasmid was subsequently removed by counterselec-
tion (30). The five arrays in LAL549 were deleted sequen-
tially using plasmids pGE1-Array12-LAL, pGE1-Array5-
LAL and pGE2-Array34-LAL (Supplementary Table S2),
to remove arrays 1+2, array 5 and arrays 3+4, respectively.
All knockoutmutants were confirmed by PCRwith primers
listed in Supplementary Table S2 (Supplementary Figure
S2).
Pull-down assay using biotinylated DNA
The promoter region of the type I-A interference gene cas-
sette was amplified by PCR using primers NoBiotin-pcsa5-
rev and Biotin-pcsa5-fwd (Supplementary Table S3). Sul-
folobus Cells were harvested at OD600 around 0.9 and re-
suspended in DNA-binding buffer (10 mM Tris-HCl, pH
7.6, 150 mM KCl, 2 mM DTT, 10% glycerol) before son-
ication. The biotinylated DNA (4 g) and 100 l M-280
Streptavidin Dynabeads (Invitrogen, 11205D) were added
to the cell extract and then mixed gently at 50◦C for 20 min.
After incubation, the beads were washed three times and
dissolved in 100 l binding buffer. A portion of the beads
was boiled and loaded for SDS-PAGE.
Protein purification and antibody preparation
csa3b (sso1444) was cloned downstream of the arabinose
promoter and upstream of the histine tag coding sequence
in pEXA3 to make pAPCsa3b-His6 for His-tagged Csa3b
(Csa3b-His6) protein expression in Sulfolobus. For Csa3b-
His6 protein expression in E.coli Rosetta cells, the pET-
30a based construct pCsa3b-His6 (SupplementaryTable S2)
was used. pAPCsa3b-His6 was transformed into S. solfa-
taricus Sens1 for Csa3b-His6 purification. Sulfolobus cells
were grown in GCVYmedium at 78◦C until OD600 reached
around 0.6. To induce Csa3b-His6 expression from the ara-
binose promoter, we transferred the culture from GCVY to
ACVY medium (0.2% arabinose was substituted for glu-
cose) and the culture was incubated overnight. Cells were
harvested by centrifugation at 8000 g for 10 min, resus-
pended in buffer (50 mM NaH2PO4 (PH 8.0), 300 mM
NaCl, 1 mM EDTA, 1 mM PMSF) and lysed by sonica-
tion. The lysate was subjected to His-tag purification us-
ing Ni-NTA agarose beads (Qiagen, Germany) according
to themanufacturer’s instruction. TheN-terminal fragment
of Csa3b containing 120 aa residues was purified from E.
coli transformed with plasmid pCsa3bpartN-His6 (Supple-
mentary Table S2) and the partial Csa3b was used to raise
polyclonal antibody in rabbit (Innovagen, Sweden).
DNase I footprinting assay
FAM fluorescence labeling capillary electrophoresis was
used for DNase I footprinting (32). First, the wild-type and
mutant forms of Pcas were PCR amplified using primers
listed in Supplementary Table S3 and the PCR products
were cloned into pJET1.2. Using these plasmids as a tem-
plate, FAM labeled DNAs were obtained by amplifying the
insert with the primer Fprintingfwd and the FAM labeled
primer FAM-pJET1.2rev (Supplementary Table S3). Next,
about 0.03 M FAM labeled DNA fragments were incu-
bated with 0.17 MCsa3b-His6 protein (purified from Sul-
folobus cells) at 37◦C for 30 min in 50 l binding buffer [20
mM HEPES (pH 7.6), 10 mM (NH4)2SO4, 1 mM DTT,
0.2% Tween-20, 30 mM KCl]. The reaction was subjected
to DNase I (0.016 units) (Thermo Scientific, EN0521) di-
gestion for 40 s at 37◦C, then stopped by addition of EDTA
at a final concentration of 60 mM and incubation at 80◦C
for 10 min. Samples were subjected to phenol–chloroform
extraction, ethanol precipitation and sent to Eurofins Ge-
nomics company (Germany) for fragment length analysis
by capillary electrophoresis.
-Galactosidase assay
All constructs including placS-77, placS-39, placS-77 RI L,
placS-77 RI R, placS-77 RII L and placS-77 RII R were
transformed into suitable Sulfolobus strains individually,
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and single colonies were isolated. -Galactosidase activity
in an equal amount of total crude proteins was measured
for each transformant, as described previously (33).
RNA isolation, quantitative RT-PCR analysis and RNA se-
quencing
Total RNAs were extracted from Sulfolobus cells (50 ml,
OD600 around 0.2) using Trizol reagent (Invitrogen) fol-
lowing the instruction of the manufacturer. Twenty micro-
grams of RNA was treated by DNase (TURBO DNA-
free™Kit, Life Technologies, AM1907) and 3.5 g DNase-
treated RNA was subjected to first strand cDNA synthe-
sis using Revert Aid First Strand cDNA Synthesis Kit
(Thermo Scientific, K1622). Quantitative PCR analysis was
conducted using the cDNAs as templates and Maxima
SYBR Green/ROX qPCRMaster Mix (Thermo Scientific,
K0221). Template cDNA, 5lMaxima SYBRGreen/ROX
qPCR Master Mix and forward and reverse primers (each
5 pmol) were mixed in each reaction system (total volume
10 l). The PCR protocol consisted of 95◦C for 5 min, 40
cycles of 95◦C for 10 s, 56◦C for 10 s and 72◦C for 20 s.
Relative amounts of RNAs were calculated using the com-
parative Ct method (34), and amplification efficiencies of
csa5 and reference tfbI sequences were validated (Supple-
mentary Figure S3). For RNA sequencing, 20 g DNase
treated RNAs were sent to BGI, Shenzhen, China followed
by standardized library construction and Illumina sequenc-
ing. The RNA-Seq data were normalized and the ratio of
CRISPR-Cas related transcripts between the knockout mu-
tants and the wild-type E233S strain was calculated by BGI
according to their standard procedure.
ChIP assay
Sulfolobus cultures (OD600 = 0.4) were fixed in 1%
formaldehyde for 10 min at 37◦C and then quenched by
adding glycine to a final concentration of 125 mM, fol-
lowed by an additional incubation of 5 min at 37◦C. Chro-
matin immunoprecipitation was performed using methods
developed by JiaGuo et al. (35). FollowingDNA extraction
with phenol/chloroform andDNAprecipitation,DNApel-
let was washed twice with 70% ethanol and resuspended in
50 l Milli-Q water, and a 0.01 l DNA solution was sub-
jected to quantitative PCR using the primer sets listed in
Supplementary Table S3.
Comparative bioinformatics
Putative Csa3 sequences were identified from genomes
present in Refseq, as of 21.03.2016, using the TIGRFAMs
hidden Markov model TIGR01884 and hmmsearch from
the HMMER 3.0 package and the model’s trusted cutoffs
(36–38). Muscle version 3.8.31 was used for multiple align-
ments. The evolutionary relationship was inferred by us-
ing the Maximum Likelihood method based on the JTT
matrix-based model (39). Initial tree(s) for the heuristic
search were obtained automatically by applying Neighbor-
Join and BioNJ algorithms to amatrix of pairwise distances
estimated using a JTT model, and then by selecting the
topology with superior log likelihood value. The tree with
the highest log likelihood (−26 217.2609) was selected and
drawn to scale, with branch lengths measured in the num-
ber of substitutions per site. The analysis included 142 aa
sequences. There were a total of 336 positions in the final
data set. Evolutionary analyses were conducted inMEGA7
(40). Sequences upstream of CRISPR-Cas type I-A inter-
ference gene cassettes were extracted manually and motifs
were identified using MEME version 4.8.1 (41).
RESULTS
Two tandem palindromic sequences in promoter Pcas are in-
volved in transcriptional regulation of the Sulfolobus type I-A
interference gene cassette.
To identify regulatory sequences in the promoter of type
I-A interference gene cassette of S. solfataricus, Pcas, we
shortened the 77 bp Pcas promoter to 62 or 39 bp upstream
of csa5, and the plasmid constructs (Figure 1B) were elec-
troporated individually into InF1 cells. In contrast to the 77
bp promoter sequence, both shortened promoter sequences
conferred toxicity to their corresponding construct because
no InF1 transformants were obtained (Figure 1C). This
suggests that a regulatory sequence in the 77 bp promoter
region was absent or incomplete in the shortened promoter
sequences. Indeed, two 18-bp tandem imperfect repeats, RI
andRII, are present immediately upstream of the basal pro-
moter, each of which contains palindromic ends that could
serve as binding sites for transcriptional regulators (Figure
2). Both repeats are missing in the 39 bp promoter whereas
the TATA box-proximal repeat (RII) remains intact and
most of the distal repeat (RI) is deleted in the 62 bp pro-
moter (Figure 1B).
Next, in order to investigate the involvement of the palin-
dromic repeats in the regulation of gene expression from
Pcas, we mutated the palindromic sequences individually
and the promoter was fused in pEXA2 vector with a re-
porter gene encoding galactosidase (LacS, SiRe2224) (Fig-
ure 2A andB). The plasmid constructs containing the short-
ened promoter (39 bp) (placS-39), or the 77 bp promoter
with or without mutations (placS-77 wild type (WT), RI
or RII mutants), were transformed individually into InF1
and the specific -galactosidase activity was measured for
each transformant. The activity was normalized for each
strain by arbitrarily setting the activity from InF1/placS-
39 as 100. As shown in Figure 2C, activity derived from the
39 bp promoter (placS-39) was more than 10 times higher
than that obtained from the 77 bp promoter (placS-77WT),
indicative of a promoter derepression in the former. Since
the only difference between the two promoter derivatives is
the tandem palindromic repeats carried by the latter, these
repeats could function in the repression of the promoter ac-
tivity. Indeed, mutation of half of each palindromic repeat
resulted in an elevated reporter gene activity (Figure 2C),
suggesting a reduced or abolished binding of repressor(s) at
the mutated sites. RI appears slightly more important than
RII as the effect of mutation is more profound for the for-
mer.
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Figure 2. Two palindromic repeats, RI andRII, are involved in transcriptional repression of Pcas in InF1 cells. (A) Depiction of inserts cloned into pEXA2-
based constructs placS-77 WT, placS-77 RI or RII mutants and placS-39. LacS is fused with Pcas or Pcas derivatives in the constructs. (B) Sequences of
Pcas and Pcas derivatives in the six constructs. Repeats RI, RII and the corresponding mutants are underlined with the mutated sequences shown in bold.
The TFB recognition element (BRE) and TATA box in the basal promoter of Pcas are indicated. The start codon of lacS gene, ATG, is shown in bold. (C)
Relative LacS activity expressed from plasmid-borne Pcas and Pcas derivatives in InF1 cells.
Csa3b binds specifically to the palindromic repeat sequences
in Pcas
A 227 bp sequence upstream of csa5 start codon was ampli-
fied by PCR with one of the two primers biotinylated. This
biotinylated DNA contains both RI and RII sites and was
used for pull-down assay to identify transcriptional regula-
tor(s) of the promoter. Cellular extracts were prepared from
Sens1 and InF1 cultures. As transcriptional repression only
occurred in InF1, no transcriptional repressor was expected
to bind to the sequence in Sens1, which was thus used as a
control. One protein was obtained from InF1 cells that was
absent from Sens1 cells in the pull-down assay and the size
(23 kDa) was similar to that of Csa3b (SSO1444). West-
ern blotting using an antibody against Csa3b (SSO1444)
revealed a specific signal at the position of the extra band
present in InF1 (Supplementary Figure S4A). Compared to
the His-tagged and thus slightly larger Csa3b expressed in
and purified from E. coli, the intensity of the Western blot
signal was proportional to that observed in Coomassie blue
stained PAGE gel (Supplementary Figure S4A). Further, a
similar band occurred in the sample obtained from the pull-
down assay with Sens1 cells carrying a plasmid-borne csa3b
(Supplementary Figure S4A). Therefore, we concluded that
the extra band in InF1 sample was Csa3b protein.
DNase I footprinting assays were performed on the pro-
moter region in the presence or absence of Csa3b protein,
using a capillary sequencer to analyze the protected regions
(32). The template strand of the DNA fragments covering
the two repeats, RI and RII, was labeled by FAM and sub-
jected to DNase I footprinting assays. In contrast to the
control (black signal), the DNA sample bound by Csa3b
(red signal) was protected overmost of the repeat region, in-
cluding both RI and RII sites (Figure 3A). Moreover, four
hypersensitive sites occurred upon Csa3b binding, corre-
sponding to the four nucleotides at the ends of the palin-
dromes (G and C in red, Figure 3A). This suggests that
binding of Csa3b on the repeat region caused DNA bend-
ingmaking the four nucleotides highly accessible for DNase
I digestion. Next, the two regulation sites (RI and RII)
were mutated individually and subjected to the same assay.
Mutation of the right palindromic part of each regulation
site prevented the protection of the corresponding site by
Csa3b and the two corresponding hypersensitive sites dis-
appeared (Figure 3B and C). This demonstrates that Csa3b
may regulate the expression of CRISPR-Cas type I-A inter-
ference gene cassette by binding to the two regulation sites
upstream of the promoter Pcas.
Cascade is involved in the transcriptional repression of the
type I-A interference gene cassette
As described above, the presence of the RI and RII se-
quences in the promoter confers more than 10 times repres-
sion in InF1 cells (Figure 2) encoding multiple CRISPR-
Cas gene cassettes (42). To establish whether Csa3b was the
sole protein responsible for the repression, the reporter gene
lacS was fused with the promoter containing both RI and
RII (promoter 77) and cloned into pEXA2 with or without
the csa3b gene (Supplementary Figure S4B). csa3b was po-
sitioned either upstream or downstream of lacS. The three
constructs were transformed into Sens1 cells lacking func-
tional CRISPR-Cas systems and the -galactosidase ac-
tivity was measured and quantified by arbitrarily setting
the activity derived from the plasmid placs-77 as 100. In
the presence of csa3b, LacS activity was reduced to about
40% (Supplementary Figure S4C), suggesting that themuch
stronger repression of the promoter in InF1 cells (>10-fold,
Figure 2) resulted from co-operation between Csa3b and
other element(s).
To assess the role of Csa3b on transcription regulation,
we deleted csa3b from S. islandicusE233S (27) which carries
a single type I-A interference gene cassette and an upstream
csa3b (Supplementary Figure S5), both of which share high
sequence similarities (86–95%) to the corresponding ho-
mologs in S. solfataricus InF1. RNAs were isolated from
both E233S and the knockout strain csa3b, and the tran-
script level of csa5, the first gene of the interference gene cas-
sette, was compared by quantitative reverse transcription
PCR (RT-PCR). The threshold cycle (Ct) values of samples,
with three technical replicates, are shown in Supplementary
Table S4A. The analysis showed that csa5 transcription was
upregulated 25 times in csa3b, indicating that Csa3b is
needed for the repression of the interference gene cassette
(Figure 4A). This is further supported by the restored tran-
scriptional repression of csa5 incsa3b cells complemented
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Figure 3. DNase I footprinting of Pcas DNA. DNase I footprinting of Pcas DNA was performed with the template strand (FAM-labeled) in the presence
(spectra in red) or absence (spectra in black) of Csa3b. (A) Wild-type or (B and C) mutated Pcas DNA were used. RI and RII sites on the coding strand
are underlined and mutated nucleotides are indicated in green. Red colored nucleotides represent DNase I hypersensitive sites on the template strand.
with a plasmid-borne csa3b (pcsa3b) expressed from its na-
tive promoter (csa3b/pcsa3b in Figure 4A).
We examined the overall effect of csa3b deletion on tran-
scription by sequencing the transcriptomes of csa3b and
the complement strain csa3b/pcsa3b with that of the
mother strain E233S as reference. Along with the three
samples, we also sequenced the transcriptomes of individ-
ual deletion mutants of the type I-A interference gene cas-
sette (csa5, cas7, cas5, cas3′, cas3′′, cas6) and
the transcriptome of two type III-B interference gene cas-
settes deletion mutants (cmrα cmrβ), all of which were
generated previously (43). As expected, the expression of all
the genes of the type I-A interference gene cassette (csa5–
cas6) was upregulated in the csa3b cells by between 14-
and 40-fold, and the repression is restored in the comple-
ment straincsa3b/pcsa3b (Supplementary Table S5A and
B). Surprisingly, deletion of any individual component of
the type I-A interference gene cassette also caused upreg-
ulated transcription of the gene cassette, with the effect of
cas7 deletion and cas6 deletion being most profound (up to
45-fold and 22-fold, respectively). The only exceptions were
the last three genes (cas3′′, cas8a and cas6) that are moder-
ately downregulated incas5 andcas3′.The upregulation
of the type I-A interference gene cassette appears specific,
because the adaptation gene cassette was not affected. Im-
portantly, deleting both cmr cassettes did not cause signifi-
cant transcriptional regulation on the type I-A interference
gene cassette. This suggests that the components of the type
I-A interference gene cassette are involved in transcriptional
repression of the gene cassette.
Next, we performed quantitative RT-PCR on csa5 to ver-
ify the upregulation of the type I-A interference gene cas-
sette in the individual deletion mutant. The threshold cycle
(Ct) values of samples, with three technical replicates, are
shown in Supplementary Table S4A. Values for the tfb I
gene were used for normalization. The normalized value
for csa5 transcript in WT was set to 1. In accordance with
the transcriptomic data, csa5 is upregulated about 45, 9,
13, 18, 19 and 26 times, in cas7, cas5, cas3′, cas3′′,
cas8a and cas6, respectively (Figure 4A). As cas6 is re-
sponsible for mature crRNA biogenesis in S. islandicus,
and deletion of cas6 caused dramatic upregulation of the
type I-A interference gene cassette, we set out to check
whether crRNAs are also involved in transcriptional repres-
sion of the gene cassette. Depletion of crRNA by deleting
the CRISPR repeat arrays along with the acquisition gene
cassette (E233Sarrays) (Supplementary Figure S5) caused
a 25-fold upregulation of csa5 transcription (Figure 4A).
The necessity of crRNA for the transcriptional repression
was further supported by the restored transcriptional re-
pression of csa5 in E233Sarrays/arrayCK cells carrying
a plasmid-borne mini-CRISPR composed of two copies of
type I-A repeat interspaced with one spacer (arrayCK, Sup-
plementary Table S2). Taken together, the data suggest that
all the type I-A interference components, including crRNA,
are involved in the transcriptional repression of the gene
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Figure 4. Regulation of Pcas in different deletion mutants derived from E233S. (A) Transcriptional level of csa5. (B) Relative LacS activity derived from
Pcas. Results from three technical replicates are shown in both A and B, and error bars indicate standard deviation. WT: E233S.
cassette, possibly through binding of Cascade to the pro-
moter region.
csa5 expression in different deletion mutants could be
influenced by other factors in addition to the promoter
strength thus causing the observed varied effects (Fig-
ure 4A). Therefore, the regulation of Pcas in the differ-
ent knockout strains was further studied using the con-
struct placS-77 (Figure 2) that carries the fusion of Pcas
(77 bp) and the reporter gene lacS. placS-77 was trans-
formed into the deletion mutants and -Galactosidase ac-
tivity was quantified by arbitrarily setting the activity from
E233S/placS-77 as 1. LacS was upregulated around 40
times in csa3b, csa5, cas7, cas5, cas8a and cas6
but only around 10 times in arrays, cas3′ and cas3′′
(Figure 4B). Possibly, two different versions of Cascade are
involved in transcriptional repression of Pcas, one compris-
ing all the components and the other missing crRNA, Cas3′
and Cas3”. This possibility is supported by previous stud-
ies suggesting the existence of subcomplexes of the type I
system (44–47).
Recruitment of Cascade to protospacers leads to Pcas dere-
pression
The requirement of crRNA and all the components of the
interference gene cassette for the repression strongly sug-
gest that the Cascade complex binds to the promoter Pcas.
However, it is not feasible to test the binding in vitro due
to the difficulty of isolating a complete and functional Cas-
cade from Sulfolobus, as experienced in our laboratory and
by others (45). Therefore, we employed a virus-host system
to investigate the effect of recruiting Cascade to viral pro-
tospacers.
Sulfolobus islandicus LAL14/1, the model host of rudi-
virus SIRV2, encodes five CRISPR arrays as well as type
I-A, type I-D and type III-B systems (48), the majority
of which were upregulated 1 h post infection by SIRV2
(14). The CRISPR arrays contain 13 spacers matching
SIRV2 genome with one to five base pair mismatches.
To avoid potential complications caused by these spacers,
we knocked out all the five arrays in Sulfolobus islandi-
cus LAL549 (a derivative of LAL14/1 carrying a partial
pyrF deletion, Supplementary Table S1) and the resultant
strain LALarrays carries one type I-A, one type I-D and
one type III-B interference gene cassette. Next we con-
structed two type I-A mini-CRISPR arrays individually in
vector pGE1 (Supplementary Table S2) targeting the coding
strand of SIRV2 gp38 (Cgp38-CCA) or the template strand of
gp38 (Tgp38-CCG). Both spacers are among the 13 natural
spacers matching SIRV2 genome, but the mismatches were
corrected in the mini-CRISPR arrays so that both spac-
ers match the viral protospacers perfectly with the typical
type I-A PAM CCN. To test the effect of the PAM motif,
we removed CCA and CCG, respectively, by shifting both
spacers 1 bp in mini-CRISPR arrays to construct Cgp38-
CAT and Tgp38-CGT (Supplementary Figure S6). The four
constructs were transformed individually into LALarrays
with arrayCK being a control which does not match either
the genome of LALarrays or that of SIRV2. The trans-
formants were grown in arabinose-containing ACVY liquid
medium until OD600 around 0.2, infected with SIRV2 (mul-
tiplicity of infection around 5) and the level of csa5 tran-
script at 1 h post infection was compared by quantitative
RT-PCR. The threshold cycle (Ct) values of samples, with
three technical replicates, are shown in Supplementary Ta-
ble S4B. In comparison with the transcript level in the cor-
responding uninfected cultures (Figure 5), csa5was upregu-
lated around 6 and 4-fold post infection in cultures contain-
ing Cgp38-CCA and Tgp38-CCG, respectively, demonstrat-
ing a transcriptional derepression of the type I-A interfer-
ence gene cassette. No upregulation of csa5 was detected in
infected cells containing the control spacer carried on ar-
rayCK. Compared to the CCN PAM for type I-A interfer-
ence complex, the use of CGTdid not lead to a release of the
repression while the use of CAT resulted in a mild release
(∼1.8-fold) of the repression. The slight release observed
with Cgp38-CAT correlates with an observed low interfer-
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Figure 5. Transcriptional regulation of csa5 in LALarrays carrying dif-
ferent plasmid-borne spacers upon SIRV2 infection. LALarrays trans-
formed with construct Tgp38-CCG, Tgp38-CGT, Cgp38-CCA, Cgp38-
CAT or arrayCK, as well as the wild-type (WT) strain LAL549, were in-
cubated with (+ SIRV2) or without SIRV2 (- SIRV2) before RNA extrac-
tion and RT-qPCR. Sample normalization was done as indicated for Fig-
ure 4A. Results from three technical replicates are shown, and error bars
indicate standard deviation.
ence activity accompanied by CAN PAM (49). Moreover,
in accordance with the transcriptomic data from SIRV2 in-
fected wild-type LAL14/1 cells (14), quantitative RT-PCR
revealed about 13-fold upregulation of csa5 in SIRV2 in-
fected cells (Figure 5). Further, 6 to 8-fold transcriptional
upregulation of csa5 was observed in SIRV2 infected cells
carrying plasmid-borne spacers that target either the coding
or the template strand of randomly selected SIRV2 genes
(gp01, gp29, gp49) (Supplementary Figure S7 and Supple-
mentary Table S4C). The plasmid-borne spacers do not
match to the chromosome of LALarrays including the in-
terference gene cassette, and thus, the observed transcrip-
tional regulation is unlikely due to direct binding of the cor-
responding crRNAs to the gene cassette. Taken together,
this result suggests that recruitment of Cascade to proto-
spacers with preferred CCN PAM reduces the amount of
Cascade binding at Pcas thereby releasing transcriptional
repression.
Csa3b-dependent binding of Cascade complex to Pcas
To further confirm the binding of Cascade to the promoter
Pcas, we performed ChIP assay with an anti-Csa5 anti-
body. S. islandicus E233S and its corresponding cas7,
cas8, arrays and csa3b cultures were treated with 1%
formaldehyde to crosslink interacting macromolecules, and
DNA bound to Cascade was co-immunoprecipitated us-
ing the anti-Csa5 antibody following DNA fragmentation.
The size distribution of the fragmented DNA, a loading
control (SDS PAGE of 5 l cell lysate) and the specificity
of Csa5-Ab were shown in Supplementary Figure S8. The
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Figure 6. In vivo binding of Cascade to Pcas. ChIP-qPCR values for the
tfbI gene were used for normalization. The normalized value for Pcas de-
rived from E233S (WT) without antibody addition was set to 1. Results
from three technical replicates are shown, and error bars indicate standard
deviation. +, with Csa5-Ab; −, without Cas5-Ab.
amount of Pcas DNA was then quantified by qPCR using
tfbI gene (704 kbp from the Pcas) as reference. The thresh-
old cycle (Ct) values of samples, with three technical repli-
cates, are shown in Supplementary Table S4D. As shown
in Figure 6, ∼7-fold more DNA from the promoter region
was detected in sample E233S precipitated by Csa5 anti-
body relative to the control where Csa5 antibody was not
added. This supports the inference that Cascade binds to
Pcas and this is further supported by the failure to detect
significant amounts of Pcas DNA in samples cas7, cas8
or arrays and by the detection of ∼5-fold more DNA in
sample arrays complemented by a plasmid-borne mini-
CRISPR (Figure 6). Interestingly, the Csa5-antibody failed
to precipitate Pcas DNA from the csa3b deletion mutant
csa3b, whereas complementation of csa3b deficiency by
a plasmid-borne csa3b (csa3b/pcsa3b) allowed precipita-
tion of 11-fold more Pcas DNA by Csa5 antibody than the
control (Figure 6). This suggests that Csa3b is needed for
Cascade binding to Pcas.
Conservation of csa3 and Pcas in archaea
We searched for Csa3 in all genomes present in the Refseq
database and retrieved 142 Csa3 sequences using the TIGR-
FAMs hidden Markov model specific for Csa3. More than
half (53%) of the csa3 genes are immediately adjacent to
CRISPR-Cas type I-A gene cassettes, and the remainder are
associated with CRISPR-Cas type I-D, type I-B, type I-C,
type I-E and/or type III (in total∼26%) as well as with non-
CRISPR related genes (∼21%) (Supplementary Table S6).
Phylogenetic analysis demonstrates that most of the Csa3
sequences associated with type I-A or type I-D gene cas-
settes are clustered together (Supplementary Figure S9).
Further analysis was performed for a major cluster com-
prising Csa3 sequences that are closely related to SSO1444
and SiRe0765, and are therefore designated Csa3b (Figure
7). These csa3b genes are all derived from genomes of Sul-
folobaceae and all except two are proximal to a type I-A
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Figure 7. Phylogenetic tree of (A) Csa3b and (B) the associated palindromic sequences in Pcas of 25 members of the Sulfolobaceae. Strain names and
Csa3b gene IDs are given in the tree. Twenty strains labeled in red carry two copies of the palindromic repeat and the other five (in black) contain only one
copy. The palindromic sequences within each subbranch are almost identical and only those from the strains shown in bold in the tree were used to build
the sequence logo.
interference gene cassette (Figure 7, Supplementary Table
S6). Moreover, the promoter regions of the immediately ad-
jacent type I-A interference gene cassettes are conserved
and mostly carry two highly similar palindromic repeats
(Figure 7). On the other hand, more than 90% of CRISPR-
Cas type I-A gene cassettes have an adjacent csa3 gene, pre-
viously designated casR (50). Taken together, this suggests
that Csa3b/Cascade mediated transcriptional repression is
likely applicable to most CRISPR-Cas type I-A systems.
DISCUSSION
We have shown that the Sulfolobus transcriptional repres-
sor Csa3b binds to two imperfect palindromic repeats
(TTTTCN8GAAAA/T) upstream of the promoter of the
type I-A interference gene cassette (Figure 3). However,
Csa3b alone can only confer a moderate level of repression
on the expression of the type I-A interference gene cassette
in Sulfolobus. All components of the type I-ACascade com-
plex, including crRNAs, are needed for complete repres-
sion (Figure 4A and B, Supplementary Table S5A and B).
Importantly, recruitment of the type I-A Cascade complex
to crRNA-matching protospacers leads to transcriptional
derepression that requires the type I-A PAM, CCN (Figure
5). Further, ChIP assay strongly suggested that the Cascade
complex binds to the promoter (Figure 6). Taken together,
the data allow us to propose the following model for tran-
scriptional regulation of CRISPR-Cas type I-A interference
gene cassette in Sulfolobus (Figure 8). In the absence of viral
infection, Cascade binds at the promoter region and main-
tains transcriptional repression in a Csa3b-dependent man-
ner. Upon viral infection Cascade is redistributed to proto-
spacer sites on the viral genome, and its binding to the pro-
moter is thus reduced allowing transcriptional activation of
the interference gene cassette.
Our data also suggest that a subcomplex of Cascade
containing Csa5, Cas7, Cas5, Cas8a and Cas6 is involved
in transcriptional repression of Pcas (Figures 4B and 8).
This subcomplex is not expected to direct viral infection
surveillance due to the lack of crRNA, Cas3′ and Cas3′′
(Figure 8). It remains an interesting question as to how
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Figure 8. Model of transcriptional regulation of CRISPR-Cas type I-A interference gene cassette. Stage 1, Pcas is repressed by Csa3b and Cascade or
Cascade subcomplex in the absence of viral infection; stage 2, a protospacer is introduced into the host cell upon viral infection; stage 3, binding of Cascade
to the protospacer reduces the amount of Cascade on Pcas, leading to transcriptional derepression. The subcomplex lacks crRNA, Cas3′ and Cas3′′, and
is thus not expected to direct viral infection surveillance (stage 2′).
this subcomplex-mediated transcriptional repression is reg-
ulated. Further, future studies are needed to elucidate
whether the complete Cascade and the subcomplex interact
in binding and repressing Pcas.
Bacterial and archaeal species often carry large arrays
of CRISPR repeat-spacer units and encode multiple cas
gene cassettes (51,52), and their expression is expected to
be maintained at a low level in the absence of invading
viruses in order to minimize energy consumption. On the
other hand, the defence system should be able to respond
quickly to viral infections. In support of this scenario, we
have shown that both Csa3b and the Cascade complex co-
operate in transcriptional repression of the type I-A in-
terference gene cassette in Sulfolobus in the absence of vi-
ral infection. Upon rudiviral SIRV2 infection, Cascade re-
distributes to crRNA-matching protospacers on the viral
DNA thereby allowing derepression of the interference gene
cassette. This strategy ensures a direct coupling between
CRISPR-Cas surveillance of an infecting virus and tran-
scriptional activation of the interference gene cassette and
thereby, enables rapid defence against the infecting virus.
To date, <10 global transcription regulators have been
identified from several bacterial organisms includingE. coli,
Salmonella Typhi, Myxococcus xanthus and Thermus ther-
mophilus, which repress or activate CRISPR-Cas transcrip-
tion (53). However, all except one were investigated in the
absence of viral infection (13). Therefore, it remains an open
questionwhether, and how, these regulators respond to viral
infection. The tight association of csa3b with type I-A in-
terference gene cassettes and the prevalence of palindromic
sequences directly upstream of the gene cassettes in some
archaea suggests that transcriptional regulation of type I-A
interference gene cassettes by Csa3b and the Cascade com-
plex may be a highly conserved and important regulation
mechanism.
S. islandicus LAL549 carries 13 spacers matching SIRV2
genome with one to five base pair mismatches. Despite be-
ing susceptible to SIRV2 infection, LAL549 wild-type cells
exhibit a degree of CRISPR-Cas interference against the
virus, as evidenced by much lower plaquing efficiency in
the wild-type cells than in the CRISPR array deletion mu-
tant LALarrays (data not shown). The partial defence
against SIRV2 could be due to the absence of spacers that
could confer strong interference activities or unknown viral
counteractive mechanisms (54,55). Nevertheless, activation
of Cascade expression is expected to confer higher interfer-
ence activity.
Virus induced transcriptional activation of CRISPR-Cas
systems has also been described for bacteria (13). Although
CRP-dependent upregulation of two cas operons was ob-
served in Thermus thermophiles HB8 upon infection by the
lytic phage PhiYS40, the regulatorymechanism remains un-
known. Moreover, upregulation of several cas genes and
multiple CRISPR loci in the infected cells was independent
of CRP. Further, CRP activates type I-F CRISPR-Cas sys-
tem in P. atrosepticum (19), whereas it represses type I-E
CRISPR-Cas system in E. coli (16,18). This suggests that
different regulatory pathways operate in different prokary-
otes.
To date, a complete and functional type I-A Cascade
complex has been isolated only from one organism, the cre-
narchaeon Thermoproteus tenax, which contains all the six
proteins encoded in the interference gene cassette, Csa5,
Cas7, Cas5, Cas8a, Cas3′ and Cas3′′ (44). In Sulfolobus sol-
fataricus, only a single subcomplex of the type I-A Cascade
has been isolated containing Cas7 andCas5 (45). Therefore,
since we find that all the six protein components, and the
crRNA, are involved in the complete repression of its own
promoter, Sulfolobus type I-A Cascade probably has a sim-
ilar composition to that of T. tenax.
Regardless of the classification of the CRISPR-Cas in-
terference (types I-V), they are all involved in protospacer
recognition and subsequent degradation of DNA/RNA
targets (10,56). In this study, we demonstrate, for the first
1912 Nucleic Acids Research, 2017, Vol. 45, No. 4
time, that the type I-A Cascade complex is directly involved
in transcriptional repression of its own gene cassette. This
mechanism enables the coupling of viral DNA surveillance
to transcriptional activation, and thereby facilitates a rapid
response to viral infections.
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